Levosulpiride
As of the edition of 20 October 2026, Levosulpiride is a small molecule: marketed, first approved in 2001 (ES); acts on DRD2 and HTR4.
Sources: FDA Orange Book and Purple Book, other approval registers, ClinicalTrials.gov, ChEMBL.
The drug
- Status
- Marketed; latest approval 2001
- Kind
- Small molecule
- Brand name
- Levogastrol
- First approved
- 7 March 2001 (ES)
- Approvals on record
- 1 in 1 region
- Holder of the most recent approval
- Laboratorios Salvat
- Registered trials
- 3, 0 stopped early
- Disease areas
- Nervous system; Eye; Heart and blood vessels; Hormones; Mental health
US protection
No US approval on record.
With no US approval on record there are no listed US patents or exclusivities.
This is the US only.
Targets
Registered trials
| Phase | Trials | Completed | Active | Stopped early |
|---|---|---|---|---|
| Phase 1 | 1 | 1 | 0 | 0 |
| Phase 2 | 1 | 0 | 1 | 0 |
| Phase 3 | 1 | 1 | 0 | 0 |
| All trials | 3 |